Clinical Trials Directory

Trials / Completed

CompletedNCT05485922

Performance of a Single-use Intermittent Micro-hole Zone Catheter

A Randomized, Open-labelled, Crossover Study Confirming Performance of a Single-use Intermittent Micro-hole Zone Catheter in a Population of Adult Male Intermittent Catheter Users

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
Coloplast A/S · Industry
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this randomized, controlled crossover study was to assess the performance of a new micro-hole zone catheter compared to a conventional 2-eyelet catheter in 42 male intermittent catheter users. The main objective of this study was to demonstrate superiority of the micro-hole zone catheter in terms of number of flow-stop episodes and residual volume at first flow-stop, with the catheterization performed by a health care professional in a hospital setting compared to a conventional two-eyelet catheter.

Detailed description

The investigation was a single-centre, randomized, controlled crossover study including 42 male participants comparing the performance of two intermittent catheters (IC). The study included an information visit (visit 0) and two test visits (visit 1 and 2) in which one catheterization with either the investigational device or the comparator device, according to a randomization scheme, was performed by a health care professional in a hospital setting assessing flow stop episodes, bladder emptying and hematuria. There were 4-14 days between each test visit (visit 1 and 2) and visit 0 and 1 could be held on the same day.

Conditions

Interventions

TypeNameDescription
DEVICEInvestigational device - intermittent catheter with a micro-hole zoneThe investigational device was a urinary catheter for bladder drainage through the urethra. The product is for intermittent use.
DEVICEComparator device -VaPro intermittent catheterThe comparator device is a urinary catheter for bladder drainage through the urethra. The product is for intermittent use.

Timeline

Start date
2022-09-23
Primary completion
2022-11-04
Completion
2022-11-04
First posted
2022-08-03
Last updated
2025-03-05
Results posted
2025-03-05

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05485922. Inclusion in this directory is not an endorsement.